|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | |
| C12N 5/0783 | |||
| G01N 33/50 |
| (11) | Number of the document | 3215165 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15802230.1 |
| Date of filing the European patent application | 2015-11-04 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/058939 |
| Date | 2015-11-04 |
| (87) | Number | WO 2016/073550 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 201462075856 P | 2014-11-05 | US |
| (72) |
O`REILLY, Richard, J., US
DOUBROVINA, Ekaterina, US
KOEHNE, Guenther, US
HASAN, Aisha, N., US
PROCKOP, Susan, E., US
|
| (73) |
Memorial Sloan Kettering Cancer Center,
1275 York Avenue, New York, NY 10065,
US
|
| (54) | METHODS OF SELECTING T CELL LINE AND DONOR THEREOF FOR ADOPTIVE CELLULAR THERAPY |
| METHODS OF SELECTING T CELL LINE AND DONOR THEREOF FOR ADOPTIVE CELLULAR THERAPY |